Supporting pharma companies to develop impactful strategies for market leadership with the customer at the centre, has been our passion at Trilations for more than 15 years.

We are taking this passion to the next level, with the second wave of the annual “Pharma Customer-Centricity Index”. This annual global survey reveals how customer-centric top pharmaceutical companies are perceived.

This study not only includes elements on physician-centricity but also patientcentricitycustomer relationshipinteraction, and clinical trial performance. It provides valuable insights into the competitive environment and performance of various pharmaceutical companies on each of these topics.

 “Pharma Customer-Centricity Index” scope:

  • Countries: EU5 (UK, ES, IT, FR, DE), USA, Brazil, Japan, China & Australia
  • Respondents: 1.550 specialists
  • Treatment areas: Oncology, Haematology, Dermatology, Rheumatology, Gastroenterology

You can consult your Pharma-Customer-Centricity Index scores and those of your competing pharma companies below. If you are interested in more detailed results, want to find out what is driving these results and how to improve them, please reach out to us.

I’d like to receive the Pharma Customer-Centricity Index report

“Get closer than ever to your customers. So close that you tell them what they need well before they realize it themselves.”
Steve Jobs

Content first wave (2020)

Feel free to browse through last year’s extra content.

Patient-Centricity Focus Group

To truly understand what Customer-Centricity means for the most important stakeholders, the Patients, we sat down and listened to them in a follow-up US Focus Group.

Four patient advocates and three leading specialists shared their view with us regarding Patient-Centricity and what this means in their daily lives, what is their definition of being Customer-Centric within pharma, what are best practices and unmet needs, etc.

Go to focus group

Podcast 2020 Customer-Centricity challenges

With this podcast, we wish to give you an overview of the takeaways out of PCCI 2020. That’s why we have invited two of our Customer-Centricity experts, Didier Dierckx & Björn Van Loy. They will look at Customer-Centricity in pharma from their field of expertise, being omnichannel Customer Engagement and innovation/advanced analytics respectively.

Go to podcast

“We are committed to serving the North American and LATAM markets from our new US office. Our unique expertise in fact-based HCP insights, applied in various frameworks across the entire pharma and medical device life cycle, help your brand and company succeed!”
Bradley Tritle General Manager Americas
“Trilations is possibly one of the best companies to combine Marketing Research and Consulting, with a well balanced Bottom-Up and Top-Down approach. where we can make business impact with fact-based decisions.”
Korkut Bilgin General Manager Japan & Asia Pacific

Related content

Did “customer centricity” bring pharmaceutical companies closer to the customer?

Did “customer centricity” bring pharmaceutical companies closer to the customer?
“Customer centricity” has become a strategic cornerstone for most if not all pharmaceutical companies over the last decade or so.

Read more